Singapore markets closed

ARS Pharmaceuticals, Inc. (SPRY)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.35+0.26 (+3.21%)
At close: 04:00PM EDT
8.27 -0.08 (-0.96%)
After hours: 06:36PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. Estimate-0.11-0.13-0.61-0.53
Low estimate-0.14-0.17-0.65-0.6
High estimate-0.08-0.09-0.57-0.46
Year ago EPS-0.16-0.18-0.57-0.61
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. EstimateN/AN/A5.34M59.68M
Low estimateN/AN/A2.68M55.36M
High estimateN/AN/A8M64M
Year ago salesN/A10k30k5.34M
Sales growth (year/est)N/AN/A17,700.00%1,017.60%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.17-0.17-0.18-0.14
Actual EPS-0.16-0.18-0.16-0.07
Difference0.01-0.010.020.07
Surprise %5.90%-5.90%11.10%50.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.11-0.13-0.61-0.53
7 days ago-0.11-0.13-0.61-0.53
30 days ago-0.15-0.16-0.69-0.34
60 days ago-0.16-0.17-0.73-0.58
90 days ago-0.18-0.18-0.74-0.7
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesSPRYIndustrySector(s)S&P 500
Current qtr.31.20%N/AN/AN/A
Next qtr.27.80%N/AN/AN/A
Current year-7.00%N/AN/AN/A
Next year13.10%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A